MedTrace Logo

A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings

NCT03968835 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-05-29

No results posted yet for this study

Summary

This is a prospective study looking to evaluate whether the treatment outcomes for patients who sustain a distal fingertip amputation are improved or no different when using biological dressings versus artificial dressings.

Conditions

  • Finger Injuries
  • Amputation, Traumatic

Interventions

OTHER

Bacitracin

For the first 30 people, bacitracin will be applied and covered with xeroform and gauze.

OTHER

Skin Graft

For the next 30 patients, the amputated composite skin and soft tissue unit will be thinned out to become a full thickness skin graft.

Sponsors & Collaborators

Principal Investigators

  • Jacques Hacquebord · New York Langone Medical Center

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-24
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03968835 on ClinicalTrials.gov